Cargando…
Modulating protein quality control
Small molecules that modulate the unfolded protein response have the potential to treat a variety of human protein misfolding diseases.
Autores principales: | Plate, Lars, Paxman, Ryan J, Wiseman, R Luke, Kelly, Jeffery W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4954752/ https://www.ncbi.nlm.nih.gov/pubmed/27435959 http://dx.doi.org/10.7554/eLife.18431 |
Ejemplares similares
-
Pharmacologic ATF6 activating compounds are metabolically activated to selectively modify endoplasmic reticulum proteins
por: Paxman, Ryan, et al.
Publicado: (2018) -
Pharmacologic ATF6 activation confers global protection in widespread disease models by reprograming cellular proteostasis
por: Blackwood, Erik A., et al.
Publicado: (2019) -
Protein aggregates are associated with replicative aging without compromising protein quality control
por: Saarikangas, Juha, et al.
Publicado: (2015) -
A protein quality control pathway at the mitochondrial outer membrane
por: Metzger, Meredith B, et al.
Publicado: (2020) -
Age-dependent aggregation of ribosomal RNA-binding proteins links deterioration in chromatin stability with challenges to proteostasis
por: Paxman, Julie, et al.
Publicado: (2022)